A novel immunotoxin reveals a new role for CD321 in endothelial cells.

A novel immunotoxin reveals a new role for CD321 in endothelial cells.

There are currently several antibody therapies that directly target tumors, and antibody-drug conjugates represent a novel moiety as next generation therapeutics. Here, we used a unique screening probe, DT3C, to identify functional antibodies that recognized surface molecules and functional epitopes...

Full description

Bibliographic Details
Main Authors: Takeshi Fukuhara, Jia Kim, Shintaro Hokaiwado, Makiko Nawa, Hayato Okamoto, Tomohiko Kogiso, Tetsuro Watabe, Nobutaka Hattori
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5640210?pdf=render

Internet

http://europepmc.org/articles/PMC5640210?pdf=render

Similar Items